MKDTY — Molecular Data Cashflow Statement
0.000.00%
IndustrialsHighly SpeculativeMicro Cap
- $0.00m
- -$10.34m
- CNY7.60bn
Annual cashflow statement for Molecular Data, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -114 | -108 | -255 | -194 | -328 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 10.9 | 16.1 | 126 | 78.5 | 56.3 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -43.5 | -96.5 | -8.07 | 16.2 | 41 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -146 | -187 | -135 | -95.8 | -234 |
Capital Expenditures | -2.65 | -1.93 | -2.24 | -1.82 | -0.116 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | -2.05 | 0 | 0 | -320 |
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -2.65 | -3.98 | -2.24 | -1.82 | -320 |
Financing Cash Flow Items | 92 | 180 | 63.1 | 0 | 16.2 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 173 | 263 | 37.3 | 149 | 529 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 25.1 | 72.2 | -99.5 | 51.2 | -46.1 |